In vivo Evans blue dye infusion allows for monitoring of auto-reperfusion and accurate delineation of the ischemic area in rat models of cardiac ischemia, reducing technical variability.
Answers are grounded in this paper and cite their sources.
May refine ischemic delineation in rodent models; extends prior techniques but leaves clinical translation open.
One major problem with animal models of cardiac ischemia is the huge variability in the degree and the actual duration of coronary occlusion, in large because of auto‐reperfusion that results in early‐onset partial‐reperfusion and the subsequent partial‐ischemia. The Evans blue dye (EBD) is a commonly used tracer for defining the boundary of ischemia in excised heart with re‐occluded coronary artery. This same dye is also commonly used in vivo for blood‐brain barrier research, and has been used safely in human subjects. In this study, we intravenously injected the rat with EBD immediately following left coronary arterial ligation in vivo, and observed its initial clear‐cut exclusion from the ischemic region. This initial exclusion was later followed by slow leakage of EBD into the ischemic region, at a pace depending on the “tightness” of the initial occlusion. Moreover, complete reperfusion of the heart resulted in the accumulation of EBD in the ischemic region, after which perfusion of the excised heart resulted in a visible clear‐cut boundary showing EBD‐filled ischemic region, which closely resembles the initial pre‐marked ischemic region. In conclusion, our refined rat model of cardiac ischemia allows for in vivo detection of early auto‐reperfusion and post hoc ex vivo detection of initial area of ischemia, and thus can effectively reduce technical variability in pre‐clinical experiments. (NSC of Taiwan)
No takes yet. Share an insight, caveat, or question.
Liao et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: